|
NI
|
Utilities |
Goldman Sachs |
Downgrade
|
Buy
→
Neutral
|
—
|
$22.5B
|
$22.17
|
-2.1%
|
-0.1%
|
+0.3%
|
+1.1%
|
-0.9%
|
+2.2%
|
|
JAZZ
|
Healthcare |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$14.5B
|
$163.25
|
-2.6%
|
-4.7%
|
-0.2%
|
+1.3%
|
-3.9%
|
-0.7%
|
|
RGA
|
Financial Services |
Credit Suisse |
Downgrade
|
Neutral
→
Underperform
|
—
|
$14.0B
|
$111.00
|
-2.7%
|
-5.4%
|
-0.4%
|
-0.6%
|
+2.4%
|
+5.8%
|
|
PODD
|
Healthcare |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$11.1B
|
$275.03
|
-1.8%
|
-2.9%
|
-1.3%
|
+4.2%
|
-0.2%
|
+1.3%
|
|
BAX
|
Healthcare |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$9.6B
|
$77.15
|
-2.5%
|
-0.4%
|
-0.6%
|
+0.2%
|
+1.0%
|
-0.1%
|
|
SSB
|
Financial Services |
Raymond James |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$9.3B
|
$73.25
|
-3.1%
|
-4.8%
|
+1.3%
|
+1.9%
|
+0.9%
|
+3.8%
|
|
COLB
|
Financial Services |
Keefe, Bruyette & Woods |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$8.5B
|
$40.79
|
-3.5%
|
-5.6%
|
+3.1%
|
+1.5%
|
-1.1%
|
+3.5%
|
|
GKOS
|
Healthcare |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$8.0B
|
$90.64
|
-1.2%
|
-2.2%
|
+0.9%
|
+2.9%
|
+0.6%
|
+2.7%
|
|
SWX
|
Utilities |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$6.4B
|
$60.33
|
-1.0%
|
-0.6%
|
+1.3%
|
-0.2%
|
-0.2%
|
+2.3%
|
|
LNC
|
Financial Services |
Credit Suisse |
Downgrade
|
Outperform
→
Underperform
|
—
|
$6.4B
|
$48.56
|
-4.5%
|
-6.3%
|
+1.7%
|
+2.5%
|
+2.6%
|
+2.8%
|
|
MTH
|
Consumer Cyclical |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$4.3B
|
$43.01
|
-4.7%
|
-6.7%
|
+3.0%
|
+1.8%
|
+1.3%
|
+0.4%
|
|
MTH
|
Consumer Cyclical |
BTIG |
Downgrade
|
Buy
→
Neutral
|
—
|
$4.3B
|
$43.01
|
-4.7%
|
-6.7%
|
+3.0%
|
+1.8%
|
+1.3%
|
+0.4%
|
|
CALX
|
Technology |
Northland Capital Markets |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$2.7B
|
$32.54
|
-3.2%
|
-7.2%
|
+5.3%
|
+3.3%
|
-2.1%
|
-0.4%
|
|
BEAM
|
Healthcare |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$2.7B
|
$99.89
|
-4.7%
|
-3.5%
|
+2.0%
|
+0.7%
|
+0.5%
|
+4.8%
|
|
DXC
|
Technology |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$1.7B
|
$29.24
|
-2.0%
|
-3.6%
|
-9.6%
|
+0.6%
|
-0.2%
|
+3.2%
|
|
OBNK
|
Financial Services |
Raymond James |
Downgrade
|
Strong Buy
→
Buy
|
—
|
$881M
|
$29.86
|
+7.1%
|
+5.8%
|
-0.3%
|
+1.8%
|
+0.0%
|
+3.7%
|
|
LXRX
|
Healthcare |
Wedbush |
Downgrade
|
Outperform
→
Neutral
|
—
|
$773M
|
$8.06
|
-0.5%
|
-1.9%
|
+4.6%
|
+9.9%
|
-5.2%
|
-1.5%
|
|
SB
|
Industrials |
Jefferies |
Downgrade
|
Buy
→
Hold
|
—
|
$701M
|
$1.66
|
-4.8%
|
+4.8%
|
+11.5%
|
+3.6%
|
+3.5%
|
+5.8%
|
|
AUTL
|
Healthcare |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$431M
|
$7.64
|
-3.0%
|
-3.8%
|
+0.8%
|
+2.8%
|
-0.8%
|
+10.4%
|
|
SFIX
|
Consumer Cyclical |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$394M
|
$99.87
|
+1.4%
|
-4.4%
|
-11.0%
|
-6.8%
|
-2.6%
|
+8.4%
|